The Stroke Research Group undertakes both experimental and clinical, on various aspects of stroke ranging from prevention to neurorehabilitation. Much of our research is translational.
Old Brains Symposium, Thursday 6th October 2016
We are hosting the Annual National University of Singapore/University of Cambridge Symposium on Thursday 6th October.
The theme this year is on Neurodegeneration and is titled – ‘Old Brains – pathways to neurodegeneration not forgetting the vessels’. It covers work ranging from epidemiology through clinical studies to molecular mechanisms.
The Symposium will be held in the Clifford Allbutt Building Lecture Theatre, located on the Cambridge Biomedical Campus site.
All are welcome and registration is free, and you can view the programme and you can register by following this link: http://onlinesales.admin.cam.ac.uk/browse/extra_info.asp?compid=1&modid=2&catid=1282&prodid=1706. We are asking if people could register in advance for planning of refreshments.
New BHF programme grant in Stroke Genetics
The Stroke Research Group has recently been awarded a five year programme grant from the British Heart Foundation to investigate the genetics of cerebral small vessel disease. This continues work demonstrating that this important type of stroke has a genetic component, and that genetics may provide novel insights into what causes it and how we might better treat it. We’ve received funding of £1,116,851 over five years. This is a collaboration with both between Public Health and Haematology at the University of Cambridge, Statistical Genetics at Kings College London, and Neurology at Massachusetts General Hospital Boston, US. It builds on previous smaller grants funded by the Stroke Association and on the WTCCC2 Ischemic Stroke Study funded by the Wellcome Trust.
For more information about what’s going on in the research group – you can read our current newsletter by clicking here
Visit our sister page, Cambridge Stroke.
Research interests of the group include:
- Genetics of stroke
- Pathophysiology and risk prediction in carotid artery disease
- Cerebral small vessel disease and vascular cognitive impairment
- Vertebral artery disease
- Clinical trials in stroke
Our research is closely linked, and co-located, with a comprehensive clinical stroke programme in Addenbrooke’s Hospital. This includes a dedicated Hyperacute Stroke Unit, the Lewin Stroke Rehabilitation Unit, and a daily TIA service. We run a National referral service for patients with monogenic forms of stroke, particularly CADASIL.